Nucleic acid ligand interaction assays

Details Nucleic acid ligand interaction assays Nucleic acid ligand interaction assays

1998-09-11

2002-07-16

Marschel, Ardin H. (Department: 1631)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C436S501000

Reexamination Certificate

active

06420109

ABSTRACT:

FIELD OF THE INVENTION
The invention is directed to the determination of relative binding affinities of various ligands to various nucleic acid sequences, and in particular to the determination of binding specificities and base pair determinants of specificity of particular ligands via a competitive binding assay.
REFERENCES
Brophy, G. P. et al., U.S. Pat. No. 5,789,179 (1998).
Campbell, A. K.,
Chemiluminescence: Principles and Applications in Biology and Medicine;
VCH, Ellis Horwood Ltd.: New York, 1988.
Cook, N. D., U.S. Pat. No. 5,665,562 (1997).
Haugland, R. P. (1996)
Handbook of Fluorescent Probes and Research Chemicals
(Spenze, M. T. Z., ed.) Molecular Probes, Eugene, Oreg.
Nieman, T., “Chemiluminescence: Techniques, Liquid-Phase Chemiluminescence”, in
Encyclopedia of Analytical Science,
pp 613-621; Academic Press: Orlando, Fla., 1995.
Cantor, C. R., “Lighting Up Hybridization”,
Nature Biotechnology
14:264 (1996).
Chen, Q., Shafer, R. H., and Kuntz, I. D.,
Biochemistry
36:11402-7 (1997).
Hart, H., U.S. Pat. No. 4,271,139 (1978) and U.S. Pat. No. 4,382,074 (1983).
Morrison, L. E. and Stols, L. M., “Sensitive Fluorescence-Based Thermodynamic and Kinetic Measurements of DNA Hybridization in Solution”,
Biochemistry
32: 3095-3104 (1993).
Morrison, L. E., Halder, T. C., and Stols, L. M., “Solution Phase Detection of Polynucleotides Using Interacting Fluorescent Labels and Competitive Hybridization”,
Anal. Biochem.
183:231-244 (1989).
Saenger, W., in
Principles of Nucleic Acid Structure
(Cantor, C. R., ed.), Springer-Verlag, New York, 1984.
Tyagi, S. and Kramer, F. R., “Molecular Beacons: Probes that Fluoresce upon Hybridization”,
Nature Biotech.
14:303-306 (1996).
Tyagi, S., Bratu, D. P., and Kramer, F. R., “Multicolor Molecular Beacons for Allele Discrimination”,
Nature Biotech.
16:49-53 (1998).
Wilson, W. D., Tanious, F. A., Fernandez-Saiz, M., and Rigl, C. T., “Evaluation of Drug-Nucleic Acid Interactions by Thermal Melting Curves” in
Methods in Molecular Biology, Vol.
90:
Drug
-
DNA Interaction Protocols
(Fox, K. R. ed.), Humana Press, Totawa, N.J. pp. 219-240.
BACKGROUND OF THE INVENTION
The specific molecular recognition of nucleic acids is fundamental to essential processes in molecular biology, including replication, transcription and translation. It has been shown that, in the majority of cases, binding of ligands to double-stranded nucleic acids stabilizes the duplex, or helical, form of DNA or RNA. (See, for example, Wilson et al.) The current understanding of the interactions between DNA or RNA and bound ligands is largely based on information obtained via biochemical and biophysical methods such as chemical and nuclease footprinting, affinity probing, UV, CD, fluorescent, and NMR spectroscopy, calorimetry, gel electrophoresis, and x-ray crystallography.
In a typical application of DNA footprinting, for example, a labeled oligonucleotide is digested with a DNA nuclease to the extent necessary to create an average of one cut per chain, producing a series of fragments differing by one base pair in length. A similar operation is performed on the oligonucleotide having a bound ligand. The ligand protects the oligonucleotide, at and around its binding site, from nuclease activity, creating a characteristic pattern of “missing” fragments at this site on a polyacrylamide gel following electrophoresis. This method suffers from the disadvantages of being very time and labor intensive, and in revealing not necessarily the critical molecular determinants for the ligand binding, but rather the area of the oligonucleotide that is shielded by the bulk of the ligand.
The most widely used method for studying nucleic acid hybridization is thermal denaturation, or melting, of duplex nucleic acids. Ligand binding has also been studied using thermal denaturation, since binding of ligands to duplex DNA or RNA tends to stabilize the helix against melting. Techniques used to observe this change include UV, fluorescent, CD and NMR spectroscopy, electrophoresis, and calorimetry.
Certain disadvantages are inherent in ligand binding studies based on observation of duplex denaturation, or melting. The methods provide information about binding only at or near the T
m
of the system, rather than at standard (25° C.) or physiological (37° C.) temperatures. Because the presence of the ligand generally raises the T
m
of the duplex, it is necessary that the ligand, e.g. the drug, be stable at this higher temperature. In addition, these methods do not routinely provide information about the binding site of the ligand (see, for example, Chen et al., 1997; Wilson et al., 1997). Therefore, the need exists for assays which are sensitive, are rapidly and simply carried out, and provide precise binding site information.
SUMMARY OF THE INVENTION
In one aspect, the invention provides a method of determining the binding affinity of a ligand to an oligonucleotide sequence. The ligand may be any of a wide range of nucleic acid binding groups, including a metal ion, a small organic molecule, a protein, a multi-protein complex, or a polynucleotide. According to the method, a mixture is formed of first and second oligonucleotides. The first oligonucleotide comprises a first group which is effective to produce a detectable signal, and the second oligonucleotide, which is effective to hybridize with the first oligonucleotide by Watson-Crick base pairing, comprises a second group which is effective to detectably alter the signal when the first and second oligonucleotides hybridize to form a duplex. In accordance with a preferred embodiment, the mixture is formed under conditions such that, in the absence of the ligand, the two oligonucleotides exist primarily in single-stranded form. The detectable signal, or lack thereof, is then observed in the absence of the ligand and in the presence of the ligand. Preferably, the ligand is added in increasing concentrations, with the mixture held at a substantially constant temperature, which may be at or near room temperature, during the addition. By titrating in the ligand and observing the change in signal, apparent K
d
can be determined for any oligonucleotide sequence.
In various embodiments of the first and second groups, the second group is effective to stimulate or magnify the signal, to reduce or quench the signal, or to otherwise modify the signal upon hybridization of the first and second oligonucleotides. For example, where the signal is emitted radiation, e.g. from a fluorescent dye, the second group may be effective to quench the radiation, or to alter the wavelength of the radiation, by absorption and reemission, upon hybridization. In another embodiment, the first group is a radioactive emitting group, and the second group comprises a scintillant. Alternatively, the first group or the second group is a chemiluminescent group.
In one embodiment, the first group is attached at the 5′-end or 3′-end of the first oligonucleotide, and the second group is attached at the 3′-end or 5′-end, respectively, of the second oligonucleotide. Alternatively, the first and second groups can be attached at any position within the oligonucleotide.
In another aspect, the invention provides a related method of determining the binding affinity of a ligand to an oligonucleotide sequence. In accordance with this method, a duplex is formed of a first oligonucleotide, comprising a first group effective to produce a detectable signal, and a second oligonucleotide, effective to hybridize with the first oligonucleotide by Watson-Crick base pairing, and comprising a second group effective to detectably alter the signal when the first and second oligonucleotides hybridize. In this method, the first and second oligonucleotides differ in length, such that the resulting duplex has an overhang region, preferably about 4-7 nucleotides in length. An unlabeled displacement strand, which is effective to displace one of the oligonucleotides from the duplex in the absence of the ligand, is then added. The effect of this addition on the signal is observed

Affiliated with

Also associated with

Rating

Nucleic acid ligand interaction assays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid ligand interaction assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid ligand interaction assays will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2883115